NAM logo

  • site map
  • contact
  • advanced search

  • home
  • news
  • treatment & care
  • hiv worldwide
  • living with hiv
  • preventing hiv
  • organisations
  • hiv basics
  • about us

Aidsmap

key topic guides


  • Russian
  • Français
  • Português
  • Español

YOU ARE HERE:
  • > home
  • >> Key topic guides
Changing treatment
Information on swtiching between anti-HIV treatment regimens, including details of when drug switches may be necessary and UK-based clinical trials investigating changing treatment.
News
  Gastrointestinal side-effects lead one in eight to change HAART regimen in first year of treatment
  Minority can have CD4 rises and no illness for more than 3 years after treatment failure
  More bad news on tenofovir/abacavir/3TC
  Meta-analysis finds PI-based HAART better than NNRTI regimens in NRTI experienced
  Can atazanavir reverse body fat changes?
Patient Information
  Changing treatment
  Resistance
Treatment & Care
  Alternative & complementary therapies
  Changing treatment
  Efavirenz switch to nevirapine for CNS toxicity
  Induction and maintenance therapy
  Resistance testing to select treatment
  Second regimens
  Starting treatment
  Treating body fat and metabolic changes - switching drugs
  UK switch or treatment interruption trials for people with controlled viral load
AIDS Treatment Update
  No Nukes?


key topic guides

  • Key topic guides
  • News categories
  • Links categories

other key topic guides

  • Adherence
  • Africa
  • Asia and Pacific
  • Changing treatment
  • Children and HIV
  • Conference reports
  • Developed world
  • Eastern Europe and Russia
  • Hepatitis
  • HIV and Cancer
  • HIV and drug use
  • HIV and sexual health
  • Latin America
  • Lipodystrophy
  • Medical tests
  • Mental health
  • Middle East
  • New drugs
  • News Features
  • Palliative care
  • Recently diagnosed
  • Resistance
  • Salvage treatment
  • Side-effects
  • Starting treatment
  • Statistics and epidemiology
  • Treatment access
  • Treatment interruptions
  • Tuberculosis
  • UK policy
  • Vaccines
  • Women and HIV


Support our work today




  • contact
  • email update
  • disclaimer
  • copyright